lipoxin a4 and Primary Peritonitis

lipoxin a4 has been researched along with Primary Peritonitis in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (12.50)18.2507
2000's8 (50.00)29.6817
2010's6 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fakhry, J; Godson, C; Guiry, PJ; Maderna, P; O'Sullivan, TP; Perretti, M; Sampaio, AL; Scannell, M; Shah, ST; Vallin, KS1
Keledjian, R; Nagulapalli, KC; Petasis, NA; Serhan, CN; Sun, YP; Tjonahen, E; Yang, R1
Brennan, E; Butler, E; Cacace, A; Chen, J; de Gaetano, M; Fallon, P; Gahan, K; Godson, C; Guiry, PJ; Hams, E; Leroy, X; Loscher, CE; Maingot, C; Marai, M; McLoughlin, A; Perretti, M; Zanetti, A1
Anuforo, OUU; Bjarnarson, SP; Freysdottir, J; Giera, M; Hardardottir, I; Jonasdottir, HS1
Arita, M; Asano, K; Betsuyaku, T; Fukunaga, K; Miyasho, T; Miyata, J; Obata, T; Seki, H; Takeda, J; Ueda, T1
Arai, H; Arita, M; Imoto, Y; Isobe, Y; Segi-Nishida, E; Sugimoto, Y; Tani, Y1
Barreda, DR; Havixbeck, JJ; Hodgkinson, JW; Rieger, AM; Wong, ME1
George, KL; Judge, E; Rossetti, RG; Serhan, CN; Skulas, A; Stebulis, JA; Sun, YP; Zurier, RB1
Flower, RJ; Norling, LV; Perretti, M; Serhan, CN; Spite, M; Yang, R1
Arita, M; Bannenberg, G; Devchand, PR; Gronert, K; Hong, S; Moussignac, RL; Serhan, CN1
Arita, M; Chiang, N; Serhan, CN; Takano, T; Watanabe, S1
Cooper, D; Gilroy, DW; Moradi-Bidhendi, N; Paul-Clark, MJ; Van Cao, T1
Bannenberg, G; Bauman, JG; Devchand, PR; Gronert, K; Guilford, WJ; Moussignac, RL; Parkinson, JF; Perez, HD; Schmidt, BA; Serhan, CN; Subramanyam, B1
Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Jiang, X; Karlsson, L; Lundeen, KA; Rao, NL; Riley, JP; Williams, KN; Xue, X1
Chiang, N; Clish, CB; Petasis, NA; Serhan, CN; Tai, HH; Takano, T1
Chiang, N; Clish, CB; Freeman, MW; Gronert, K; O'Brien, JA; Serhan, CN1

Other Studies

16 other study(ies) available for lipoxin a4 and Primary Peritonitis

ArticleYear
Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.
    Journal of medicinal chemistry, 2007, Nov-29, Volume: 50, Issue:24

    Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Humans; Laminin; Lipoxins; Mice; Neutrophils; Peritonitis; Phagocytosis; Stereoisomerism; Structure-Activity Relationship

2007
Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties.
    Bioorganic & medicinal chemistry letters, 2008, Feb-15, Volume: 18, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzene Derivatives; Drug Design; Drug Stability; Lipoxins; Mice; Neutrophil Infiltration; Oxidoreductases; Peritonitis

2008
Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A
    European journal of medicinal chemistry, 2019, Jan-15, Volume: 162

    Topics: Animals; Cell Line; Humans; Imidazoles; Inflammation; Lipoxins; Mice; Molecular Mimicry; Monocytes; NF-kappa B; Oxazoles; Peritonitis; Receptors, Formyl Peptide

2019
Natural killer cells play an essential role in resolution of antigen-induced inflammation in mice.
    Molecular immunology, 2018, Volume: 93

    Topics: Animals; Antibodies; Antigens; Apoptosis; Chemokines; Dinoprostone; Female; G(M1) Ganglioside; Granulocyte Colony-Stimulating Factor; Immunophenotyping; Inflammation Mediators; Interleukin-12 Subunit p40; Killer Cells, Natural; Lipoxins; Lymph Nodes; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Peritonitis; Receptors, Natural Killer Cell; Serum Albumin, Bovine; Spleen

2018
Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*.
    Critical care medicine, 2014, Volume: 42, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ceftazidime; Drug Therapy, Combination; Escherichia coli Infections; Inflammation Mediators; Lipoxins; Macrophages; Male; Mice; Mice, Inbred C57BL; Peritonitis; Sepsis

2014
Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014, Volume: 28, Issue:9

    Topics: Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Cells, Cultured; Chemokine CXCL13; Eosinophils; Flow Cytometry; Hypertrophy; Inflammation; Lipoxins; Lymph Nodes; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microarray Analysis; Peritonitis

2014
Neutrophil contributions to the induction and regulation of the acute inflammatory response in teleost fish.
    Journal of leukocyte biology, 2016, Volume: 99, Issue:2

    Topics: Acute Disease; Animals; Apoptosis; Goldfish; Immunity, Innate; Kidney; Leukotriene B4; Lipoxins; Macrophage Activation; Macrophages, Peritoneal; Neutrophils; Peritonitis; Phagocytosis; Reactive Oxygen Species; Respiratory Burst; Time Factors; Zymosan

2016
Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009, Volume: 23, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Cannabinoids; Dronabinol; Fibroblasts; Humans; Lipoxins; Male; Mice; Neutrophils; Peritonitis

2009
Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing.
    Journal of immunology (Baltimore, Md. : 1950), 2011, May-15, Volume: 186, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Aspirin; Cell Movement; Chromatography, Liquid; Docosahexaenoic Acids; Humans; Inflammation; Keratinocytes; Lipids; Lipoxins; Male; Mice; Microspheres; Molecular Mimicry; Nanoparticles; Neutrophils; Peritonitis; Tandem Mass Spectrometry; Temporomandibular Joint; Temporomandibular Joint Disorders; Wound Healing

2011
Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003, Volume: 17, Issue:6

    Topics: 3T3 Cells; Animals; Cell Line; Chromatography, Liquid; Dinoprostone; Female; Humans; Hydroxyeicosatetraenoic Acids; Inflammation; Leukotriene B4; Lipoxins; Male; Mass Spectrometry; Mice; Mice, Transgenic; Neutrophil Infiltration; NF-kappa B; Peritoneum; Peritonitis; Plasmids; Receptors, Cell Surface; Receptors, Formyl Peptide; Receptors, Lipoxin; Skin; Transfection; Tumor Necrosis Factor-alpha; Zymosan

2003
A novel rat lipoxin A4 receptor that is conserved in structure and function.
    British journal of pharmacology, 2003, Volume: 139, Issue:1

    Topics: Amino Acid Sequence; Animals; Base Sequence; Caseins; Cell Line; Conserved Sequence; Humans; Lipoxins; Male; Mice; Molecular Sequence Data; Neutrophil Infiltration; Neutrophils; Organ Specificity; Peritonitis; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Lipoxin; Reverse Transcriptase Polymerase Chain Reaction; Sequence Homology, Amino Acid

2003
15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation.
    The Journal of experimental medicine, 2004, Jul-05, Volume: 200, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Endothelium; Inflammation; Interleukin-1; Leukocytes; Lipoxins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Peritonitis; Rats; Rats, Wistar

2004
Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration.
    British journal of pharmacology, 2004, Volume: 143, Issue:1

    Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ear, External; Inflammation; Injections, Intravenous; Lipoxins; Lung Diseases; Male; Mice; Peritonitis; Reperfusion Injury; Zymosan

2004
Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 321, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Ascitic Fluid; Benzothiazoles; Dogs; Ear; Edema; Eicosanoids; Enzyme Inhibitors; Epoxide Hydrolases; Female; Humans; Hydroxyurea; Inflammation; Leukotriene B4; Leukotriene C4; Lipoxins; Lipoxygenase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Neutrophil Infiltration; Peritonitis; Piperidines; Recombinant Proteins

2007
Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:2

    Topics: Animals; Aspirin; Cell Line; Chromatography, Liquid; Enzyme-Linked Immunosorbent Assay; Exudates and Transudates; Humans; Hydroxyeicosatetraenoic Acids; Lipoxins; Mass Spectrometry; Mice; Neutrophil Activation; Neutrophils; Peritonitis; Sensitivity and Specificity

1998
Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
    The Journal of clinical investigation, 1999, Volume: 104, Issue:3

    Topics: Animals; Arachidonate 5-Lipoxygenase; Aspirin; Cell Line; Cell Movement; Crosses, Genetic; Ear, External; Exudates and Transudates; Female; Hindlimb; HL-60 Cells; Humans; Hydroxyeicosatetraenoic Acids; Lipoxins; Male; Mice; Mice, Transgenic; Neutrophils; Peritonitis; Receptors, Cell Surface; Receptors, Formyl Peptide; Receptors, Leukotriene B4; Receptors, Lipoxin; Reperfusion Injury; RNA, Messenger

1999